Choi J-H, Chung HC, Yoo NC, Lee HR, Lee KH, Choi W, Lim HY, Koh EH, Kim J-H, Roh JK, Kim SK, Lee WY, Kim BS: Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. Lung Cancer 10:287-296, 1994

Choi J-H, Chung HC, Yoo NC, Lee HR, Lee KH, Kim J-H, Roh JK, Min JS, Lee KS, Kim BS, Lim HY: Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer. Oncology 52:170-175, 1995

Choi J-H, Chung HC, Yoo NC, Lee HR, Lee KH, Kim J-H, Roh JK, Park JS, Min JS, Lee KS, Kim BS, Lim HY: Gastric cancer in young patients who underwent curative resection: comparative study with older patients. Am J Clin Oncol 19:45-48, 1996

Choi J-H, Oh JY, Ryu SK, Kim SJ, Lee NY, Kim YS, Yi SY, Shim KS, Han WS: Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. Cancer 79:1879-1883, 1997

Choi J-H, Choi GB, Shim KN, Sung SH, Han WS, Baek SY: Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy. Acta Haematol 97:231-235, 1997

Choi J-H, Kim HC, Lim HY, Nam DK, Kim HS, Yi SY, Shim K-S, Han WS: Detection of transforming growth factor-α in the serum of gastric carcinoma patients. Oncology 57:236-241, 1999

Choi J-H, Lim H-Y, Nam DK, Kim HS, Cho DY, Yi JW, Kim HC, Cho YK, Kim MW, Joo HJ, Lee KB, Kim KB: Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer 84:186-192, 2001

Choi J-H, Kim HC, Lim H-Y, Nam DK, Kim HS, Yi JW, Chun M, Oh YT, Kang S, Park KJ, Hwang SC, Lee YH, Hahn MH: Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts. Lung Cancer 33:171-179, 2001

Choi J-H , Lim H-Y, Joo HJ, Kim HS, Yi JW, Kim HC, Cho YK, Kim MW, Lee KB: Expression of multidrug-resistance-associated protein1, P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection Br J Cancer 86:1578-1585, 2002

Choi JH, Chun KH, Raz A, Lotan R: Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3. Cancer Biol Ther 2004 3:447-452, 2004

Lee HW, Choi JH, Lim HY, Park JS, Kim HC, Kang S, Oh YT, Chun M, Sheen SS, Oh YJ, Park KJ, Hwang SC: The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer - single institution retrospective analysis. Neoplasma 53:30-36, 2006

Kang SY, Oh YT, Han JH, Choi J-H, Lim H-Y, Kim HI, Lee HW, Jang JH, Park JS, Kim HC, Kang S, Chun M, Kim CH, Joo HJ: Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. Neoplasma 53:450-456, 2006

Choi JH, Kim YB, Lim HY, Park JS, Kim HC, Cho YK, Han SW, Kim MW, Joo HJ: 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion. Hepatogastroenterology 54:290-297, 2007

Kang SY, Han JH, Lee KJ, Choi J-H, Park JI, Kim HI, Lee H-W, Jang JH, Park JS, Kim HC, Kang S, Oh YT, Chun M, Kim JH, Sheen SS, Lim HY: Low expression of bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Clin Cancer Res 13:4146-4153, 2007

Lee HW, Han JH, Kim JH, Lee MH, Jeong SH, Kang SY, Choi JH, Oh YT, Park KJ, Hwang SC, Sheen SS, Lim HY: Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer. Lung Cancer 59:95-104, 2008

Jeong SH, Lee HW, Han JH, Kang SY, Choi JH, Jung YM, Choi H, Oh YT, Park KJ, Hwang SC, Sheen SS, Oh YJ, Kim JH, Lim HY: Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. Jpn J Clin Oncol 38:661-669, 2008

Lee HW, Choi YW, Han JH, Kim JH, Jung JH, Jeong SH, Kang SY, Choi JH, Oh YT, Park KJ, Hwang SC, Sheen SS. Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy. Lung Cancer 65:377-382, 2009

Jeong SH, Jung JH, Han JH, Kim JH, Choi YW, Lee HW, Kang SY, Hwang YH, Ahn MS, Choi JH, Oh YT, Chun M, Kang S, Park KJ, Hwang SC, Sheen SS. Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy. Lung Cancer 68:288-294, 2010

Lee HW, Hwang YH, Han JH, Choi JH, Kang SY, Jeong SH, Ann MS, Oh YT, Kim JH, Kim CH, Sheen SS. High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer. Oral Oncol 46:209-213, 2010

Jeong SH, Han JH, Kim JH, Ahn MS, Hwang YH, Lee HW, Kang SY, Park JS, Choi JH, Lee KJ, Sheen SS, Lim HY. Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. Dig Dis Sci 56:131-138, 2011

Kang SY, Han JH, Ahn MS, Lee HW, Jeong SH, Park JS, Cho YK, Han SU, Kim YB, Kim JH, Sheen SS, Lim HY, Choi JH. Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer 130:948-958, 2012

Ahn MS, Kang SY, Lee HW, Jeong SH, Park JS, Lee KJ, Cho YK, Han SU, Lee SY, Lim HY, Choi JH. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. Onkologie 36:421-426, 2013

Choi YW, Ahn MS, Jeong GS, Lee HW, Jeong SH, Kang SY, Park JS, Choi JH, Lee SY. Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? Lung Cancer 87:155-161, 2015

Kang SY, Ahn MS, Song GW, Choi YW, Lee HW, Jeong SH, Park JS, Cho YK, Han SU, Sheen SS, Han JH, Choi JH. Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome? Acta Oncol 54:1231-1234, 2015

Choi YW, Ahn MS, Choi JH, Lee HW, Kang SY, Jeong SH, Park JS, Han JH, Kim JH, Sheen SS.High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy. Int J Hematol103:210-218, 2016

Choi YW, Jeon SY, Jeong GS, Lee HW, Jeong SH, Kang SY, Park JS, Choi JH, Koh YW, Han JH, Sheen SS.EGFR Exon 19 deletion is associated with favorable overall survival after first-line gefitinib therapy in advanced non-small cell lung cancer patients. .Am J Clin Oncol 41:385?390, 2018

Choi YW, Ahn MS, Jeong GS, Lee HW, Jeong SH, Kang SY, Park JS, Choi JH, Sheen SS. The role of third-line chemotherapy in recurrent or metastatic gastric cancer: a cohort study with propensity score matching analysis. Medicine 97:e12588, 2018

Choi YW, Ahn MS , Jeong GS , Lee HW, Jeong SH, Kang SY, Park JS , Choi JH, Son SY, Hur H, Han SU, Sheen SS. The role of surgical resection before palliative chemotherapy in advanced gastric cancer. Scientific Reports 9:4136, 2019